Course Exam
301908 VO Development of novel cancer immunotherapies (2021S)
from target identification through target validation to clinical trials
Labels
REMOTE
WHEN?
digitale schriftliche Prüfungen mit offenen Fragen mittels eines Prüfungsbogens zum Download
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Mo 01.03.2021 09:00 to Su 12.09.2021 09:00
- Deregistration possible until Su 12.09.2021 09:00
Examiners
Information
Assessment and permitted materials
Written exam, alternative: presentation
Minimum requirements and assessment criteria
Understanding of the basic mechanisms of resistance development and of newest technologies
Last modified: Fr 12.05.2023 00:24